Roissy CDG - SIFA (Roissy CDG) (Formerly known as SIFA Transit)
SIFA Healthcare is a 100% French, family-owned freight forwarding and logistics company with a storied heritage dating back to 1951, operating from a strategic base near Paris and delivering comprehensive health-product logistics on a global scale. The healthcare division is dedicated to pharmaceutical and medical shipments, offering a fully traceable chain of custody and a robust framework designed to protect product integrity from origin to final delivery. Core to its value proposition is a strong emphasis on compliance, safety, and operational control, underpinned by industry-grade certifications, advanced temperature-controlled capabilities, and end-to-end support that spans the entire supply chain. SIFA Healthcare leverages a physically integrated infrastructure, sophisticated information systems, and seasoned personnel to protect the quality and efficacy of healthcare products in transit, including highly regulated items such as vaccines, biologics, narcotics, and veterinary medicines, as well as medical devices and cosmetics used in clinical and consumer contexts.
A defining strength is the company’s emphasis on Good Distribution Practices (GDP) compliance, reinforced by CERTIPHARM certification since 2016. This combination signals rigor in product handling, storage, and distribution, from procurement through to final mile delivery. SIFA Healthcare’s approach is designed to minimize risk and maximize product integrity through every transit phase, integrating quality assurance with practical logistics execution. The organization’s pharmaceutical-grade orientation is complemented by a dedicated pharmaceutical logistics division that orchestrates activities at departure and arrival points across served territories, ensuring a consistent, compliant, and secure experience for manufacturers, distributors, and healthcare providers.
Infrastructure plays a pivotal role in SIFA Healthcare’s capability set. The company operates with a substantial footprint that includes 60,000 square meters of warehousing space, which supports scale, speed, and capacity to manage large volumes of healthcare products. The warehousing is equipped with temperature-controlled spaces tailored to the health sector’s stringent requirements, including storage options for standard controlled environments (+2°C to +8°C, +15°C to +25°C) as well as negative climates, enabling the safe handling of sensitive items such as biologics, vaccines, and narcotic products. The presence of bonded warehousing further enhances security and regulatory compliance for international shipments that require specific duty arrangements, while climate-controlled chambers and certified environmental controls provide consistent conditions for products with narrow temperature tolerances.
SIFA Healthcare is prepared to handle a wide spectrum of health-related goods. Its portfolio includes medications (including narcotics and psychotropic drugs), vaccines, biological products, veterinary products, medical devices, medical equipment, and cosmetics. The facility design incorporates dedicated areas for handling health products and infrastructure adapted for narcotics and psychotropic drugs, addressing both regulatory requirements and operational safety. Management and follow-up for quarantined health products is part of the service offering, ensuring that items posing regulatory, safety, or integrity concerns can be segregated and managed with proper documentation and control. The result is a logistics environment that maintains product quality while facilitating complex, multi-product healthcare campaigns and everyday healthcare supply chains.
A cornerstone of SIFA Healthcare’s value proposition is pharmacist-led oversight of the entire supply chain. This practitioner-level supervision complements the sales and customer-service teams, ensuring that clinical and regulatory considerations are integrated into logistics decisions. Such supervision supports risk mitigation, batch integrity, and compliance with industry standards, while also fostering trust with pharmaceutical manufacturers, healthcare providers, and distributors who demand rigorous stewardship of sensitive products.
Beyond physical infrastructure, SIFA Healthcare places a high premium on visibility and control through real-time traceability. Customers can monitor all health products in real time via a dedicated customer space, gaining visibility at every stage—from supplier order placement through warehouse receipt, consolidation, shipping, and final delivery. This end-to-end traceability allows customers to access transport-related documents and critical milestones, supporting inventory planning, regulatory reporting, and quality assurance activities. The platform’s emphasis on data security aligns with EU data protection principles (GDPR), delivering confidence that sensitive information is protected and managed responsibly.
SIFA Healthcare strengthens its service through a structured, department-based approach at departure and arrival points across served territories. Forwarding processes are overseen by dedicated teams who ensure high-quality transport and secure handling of products throughout the chain. In-house customs clearance capabilities streamline regulatory compliance, reduce delays, and enhance end-to-end delivery performance. The combination of local expertise with a global reach translates into timely, compliant, and traceable shipments, which is essential for healthcare products that require precise handling and documentation.
Add to this a comprehensive service ecosystem that includes refrigerated vehicles and solutions at both departure and arrival points, refrigerated containers for maritime consolidation, and robust temperature management across supply chains. These capabilities support a true cold-chain architecture, enabling shipments to be maintained within validated temperature ranges throughout transit, which is a non-negotiable requirement for vaccines, biologics, and other temperature-sensitive health products. The company also emphasizes multi-daily deliveries, allowing for frequent replenishment cycles and responsive service levels that align with the needs of hospitals, clinics, and distribution centers.
From a services perspective, SIFA Healthcare offers a broad and practical range of products and capabilities that are essential to pharma logistics. In addition to medications (including narcotics and psychotropic drugs), vaccines, and biologics, the portfolio includes veterinary products, medical devices, medical equipment, and cosmetics. This breadth supports the needs of pharmaceutical manufacturers, distributors, and healthcare systems seeking a single provider capable of handling diverse product types within a unified quality and compliance framework.
The organization’s certifications and market positioning reinforce trust and reliability. GDP compliance is central to SIFA Healthcare’s operations, ensuring adherence to industry standards for distribution of healthcare products. CERTIPHARM certification reinforces the commitment to quality and safety in pharmaceutical logistics, signaling to customers that SIFA Healthcare maintains tested and validated processes across its network. Acknowledging the broader ecosystem, SIFA Healthcare also highlights its role within the customs-process landscape with relevant quality indicators and process controls that support efficient, compliant import/export activities.
The operational and strategic advantages culminate in a compelling value proposition for manufacturers, distributors, contract manufacturers, hospitals, and clinics. The combination of a pharmacist-led supervision model, a disciplined approach to QA and compliance, a robust cold-chain infrastructure, and a scalable warehousing and transport network positions SIFA Healthcare as a trusted partner for critical healthcare logistics. The company’s dedication to transparency, performance measurement, and client-specific reporting helps customers optimize supply chain performance, anticipate regulatory and capacity considerations, and sustain patient-centric service levels.
From a platform perspective, FreightCue users seeking dependable pharmaceutical logistics can view SIFA Healthcare as a high-caliber, governance-focused partner capable of meeting stringent regulatory and operational requirements. The platform enables healthcare shippers to request quotes, compare service offerings, and review performance when selecting a forwarder. With SIFA Healthcare’s track-and-trace capabilities, real-time visibility, and a formalized governance framework around GDP and CERTIPHARM standards, FreightCue users can engage with a provider that emphasizes accountability, quality, and measurable outcomes. The combination of defined service standards, extensive temperature-controlled facilities, and pharmacist-guided oversight makes SIFA Healthcare a compelling listing for any pharmaceutical supply chain, from routine distribution to complex, high-regulation campaigns. In short, SIFA Healthcare embodies a platform-ready, quality-first solution for pharmaceutical logistics that aligns with FreightCue’s marketplace model, enabling clearer comparisons, validated capabilities, and credible recommendations for healthcare shipments.
